ROXA-005
|
|
ROXA-005 Eigenschaften
- Siedepunkt:
- 573.6±50.0 °C(Predicted)
- Dichte
- 1.295±0.06 g/cm3(Predicted)
- pka
- 4.50±1.00(Predicted)
Sicherheit
ROXA-005 Chemische Eigenschaften,Einsatz,Produktion Methoden
ROXA-005 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
ROXA-005 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 7)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
Jinan Ruisi Pharmaceutical Technology Co., LTD | 0531-69900633 18340090523 |
changyuan20@163.com | China | 2585 | 58 |
Nanjing wangzhixing Pharmaceutical Technology Co., Ltd | 15850510341 |
shiqingran@wzxchem.com | China | 3713 | 58 |
Shandong WorldSun Biological Technology Co., Ltd. | 0531-88723173 18596073690 |
1047208234@qq.com | China | 4376 | 58 |
Nanjing Huanuo Biomedical Technology Co., Ltd | 18913906212 |
2885426135@qq.com | China | 7010 | 58 |
Shanghai Haohong Scientific Co., Ltd. | 400-400-8210725 |
malulu@leyan.com | China | 39990 | 58 |
Shanghai Easy CDMO Co.,Ltd | 021-61734564 |
August@easycdmo.com | China | 10031 | 58 |
Guangzhou Zhenlin Pharmaceutical Technology Co., Ltd | 18102736234 18102736234 |
2208093734@qq.com | China | 7664 | 58 |
- ROXA-005
- RSSYY(Iberdomide)-20
- 3-Isoquinolinecarboxylic acid, 1,2-dihydro-4-hydroxy-1-oxo-7-phenoxy-, butyl ester
- butyl 1,4-dihydroxy-7-phenoxyisoquinoline-3-carboxylate
- Butyl 1,2-dihydro-4-hydroxy-1-oxo-7-phenoxy-3-isoquinolinecarboxylate
- 808115-51-7